Central African Republic

Central African Republic

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
9.52 (9.23 - 9.85) 2019 Modelled IHME
9.97 (9.68 - 10.31) 2018 Modelled IHME
10.18 (9.85 - 10.53) 2017 Modelled IHME
10.18 (9.88 - 10.51) 2016 Modelled IHME
10.18 (9.85 - 10.51) 2015 Modelled IHME
10.25 (9.92 - 10.57) 2014 Modelled IHME
10.41 (10.09 - 10.75) 2013 Modelled IHME
10.63 (10.31 - 10.98) 2012 Modelled IHME
10.87 (10.54 - 11.23) 2011 Modelled IHME
11.08 (10.73 - 11.47) 2010 Modelled IHME
11.28 (10.94 - 11.67) 2009 Modelled IHME
11.51 (11.16 - 11.90) 2008 Modelled IHME
11.72 (11.38 - 12.13) 2007 Modelled IHME
11.9 (11.52 - 12.33) 2006 Modelled IHME
12.02 (11.62 - 12.47) 2005 Modelled IHME
12.08 (11.69 - 12.52) 2004 Modelled IHME
12.13 (11.74 - 12.57) 2003 Modelled IHME
12.17 (11.78 - 12.61) 2002 Modelled IHME
12.21 (11.79 - 12.66) 2001 Modelled IHME
12.26 (11.83 - 12.71) 2000 Modelled IHME
12.31 (11.88 - 12.76) 1999 Modelled IHME
12.36 (11.95 - 12.82) 1998 Modelled IHME
12.42 (12.01 - 12.86) 1997 Modelled IHME
12.48 (12.07 - 12.93) 1996 Modelled IHME
12.54 (12.12 - 13.02) 1995 Modelled IHME
12.62 (12.20 - 13.08) 1994 Modelled IHME
12.7 (12.28 - 13.17) 1993 Modelled IHME
12.8 (12.38 - 13.26) 1992 Modelled IHME
12.9 (12.47 - 13.39) 1991 Modelled IHME
13.01 (12.56 - 13.50) 1990 Modelled IHME
10.2 (8.17 - 12.63) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
3.31 (2.94 - 3.75) 2019 Modelled IHME
3.91 (3.49 - 4.36) 2018 Modelled IHME
4.16 (3.69 - 4.69) 2017 Modelled IHME
4.1 (3.64 - 4.58) 2016 Modelled IHME
3.99 (3.54 - 4.52) 2015 Modelled IHME
3.91 (3.48 - 4.41) 2014 Modelled IHME
3.82 (3.40 - 4.28) 2013 Modelled IHME
3.74 (3.33 - 4.18) 2012 Modelled IHME
3.68 (3.29 - 4.13) 2011 Modelled IHME
3.66 (3.26 - 4.12) 2010 Modelled IHME
4.01 (3.58 - 4.47) 2009 Modelled IHME
4.85 (4.34 - 5.38) 2008 Modelled IHME
5.87 (5.22 - 6.49) 2007 Modelled IHME
6.75 (6 - 7.48) 2006 Modelled IHME
7.17 (6.32 - 8.01) 2005 Modelled IHME
7.24 (6.43 - 8.11) 2004 Modelled IHME
7.29 (6.50 - 8.18) 2003 Modelled IHME
7.32 (6.54 - 8.28) 2002 Modelled IHME
7.36 (6.58 - 8.35) 2001 Modelled IHME
7.4 (6.58 - 8.42) 2000 Modelled IHME
7.44 (6.64 - 8.42) 1999 Modelled IHME
7.48 (6.64 - 8.44) 1998 Modelled IHME
7.52 (6.66 - 8.47) 1997 Modelled IHME
7.57 (6.67 - 8.52) 1996 Modelled IHME
7.61 (6.68 - 8.65) 1995 Modelled IHME
7.66 (6.74 - 8.67) 1994 Modelled IHME
7.71 (6.81 - 8.71) 1993 Modelled IHME
7.77 (6.88 - 8.74) 1992 Modelled IHME
7.83 (6.95 - 8.84) 1991 Modelled IHME
7.89 (6.97 - 8.99) 1990 Modelled IHME
6.62 (5.12 - 8.62) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
29 (21 - 37) 2019 Modelled IHME
29 (22 - 38) 2018 Modelled IHME
30 (22 - 39) 2017 Modelled IHME
30 (22 - 39) 2016 Modelled IHME
30 (22 - 38) 2015 Modelled IHME
30 (22 - 38) 2014 Modelled IHME
30 (22 - 39) 2013 Modelled IHME
30 (22 - 38) 2012 Modelled IHME
30 (23 - 39) 2011 Modelled IHME
30 (22 - 39) 2010 Modelled IHME
30 (22 - 38) 2009 Modelled IHME
30 (22 - 38) 2008 Modelled IHME
30 (23 - 39) 2007 Modelled IHME
30 (23 - 39) 2006 Modelled IHME
30 (23 - 39) 2005 Modelled IHME
30 (23 - 39) 2004 Modelled IHME
30 (23 - 39) 2003 Modelled IHME
30 (23 - 39) 2002 Modelled IHME
30 (23 - 39) 2001 Modelled IHME
30 (23 - 39) 2000 Modelled IHME
30 (23 - 39) 1999 Modelled IHME
30 (23 - 39) 1998 Modelled IHME
30 (23 - 39) 1997 Modelled IHME
30 (23 - 39) 1996 Modelled IHME
30 (23 - 39) 1995 Modelled IHME
30 (23 - 40) 1994 Modelled IHME
30 (22 - 40) 1993 Modelled IHME
30 (22 - 39) 1992 Modelled IHME
30 (22 - 39) 1991 Modelled IHME
29 (22 - 39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
47 2018 Survey/reported WHO/UNICEF
47 2017 Survey/reported WHO/UNICEF
47 2016 Survey/reported WHO/UNICEF
47 2015 Survey/reported WHO/UNICEF
47 2014 Survey/reported WHO/UNICEF
23 2013 Survey/reported WHO/UNICEF
47 2012 Survey/reported WHO/UNICEF
47 2011 Survey/reported WHO/UNICEF
45 2010 Survey/reported WHO/UNICEF
42 2009 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3.24 (2.58 - 4.05) 2019 Modelled IHME
3.24 (2.61 - 4.05) 2018 Modelled IHME
3.24 (2.62 - 4.06) 2017 Modelled IHME
3.23 (2.63 - 4.02) 2016 Modelled IHME
3.22 (2.60 - 3.96) 2015 Modelled IHME
3.19 (2.59 - 3.93) 2014 Modelled IHME
3.15 (2.57 - 3.89) 2013 Modelled IHME
3.11 (2.54 - 3.84) 2012 Modelled IHME
3.08 (2.50 - 3.82) 2011 Modelled IHME
3.07 (2.49 - 3.82) 2010 Modelled IHME
3.07 (2.49 - 3.82) 2009 Modelled IHME
3.08 (2.50 - 3.84) 2008 Modelled IHME
3.09 (2.51 - 3.85) 2007 Modelled IHME
3.11 (2.51 - 3.86) 2006 Modelled IHME
3.12 (2.52 - 3.89) 2005 Modelled IHME
3.15 (2.54 - 3.92) 2004 Modelled IHME
3.18 (2.55 - 3.97) 2003 Modelled IHME
3.22 (2.59 - 4.01) 2002 Modelled IHME
3.25 (2.61 - 4.05) 2001 Modelled IHME
3.26 (2.63 - 4.07) 2000 Modelled IHME
3.26 (2.63 - 4.07) 1999 Modelled IHME
3.27 (2.65 - 4.07) 1998 Modelled IHME
3.27 (2.64 - 4.07) 1997 Modelled IHME
3.27 (2.65 - 4.07) 1996 Modelled IHME
3.27 (2.66 - 4.06) 1995 Modelled IHME
3.27 (2.66 - 4.06) 1994 Modelled IHME
3.27 (2.65 - 4.08) 1993 Modelled IHME
3.28 (2.65 - 4.11) 1992 Modelled IHME
3.29 (2.66 - 4.12) 1991 Modelled IHME
3.29 (2.65 - 4.16) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
39 (29 - 48) 2019 Modelled IHME
38 (28 - 47) 2018 Modelled IHME
37 (28 - 47) 2017 Modelled IHME
37 (28 - 47) 2016 Modelled IHME
37 (28 - 47) 2015 Modelled IHME
37 (28 - 47) 2014 Modelled IHME
37 (28 - 46) 2013 Modelled IHME
37 (28 - 46) 2012 Modelled IHME
37 (28 - 46) 2011 Modelled IHME
37 (28 - 46) 2010 Modelled IHME
37 (28 - 46) 2009 Modelled IHME
37 (27 - 46) 2008 Modelled IHME
37 (27 - 45) 2007 Modelled IHME
37 (27 - 45) 2006 Modelled IHME
37 (27 - 46) 2005 Modelled IHME
37 (27 - 46) 2004 Modelled IHME
37 (27 - 46) 2003 Modelled IHME
37 (27 - 46) 2002 Modelled IHME
37 (27 - 46) 2001 Modelled IHME
37 (28 - 46) 2000 Modelled IHME
37 (27 - 46) 1999 Modelled IHME
37 (27 - 46) 1998 Modelled IHME
37 (27 - 46) 1997 Modelled IHME
36 (27 - 46) 1996 Modelled IHME
36 (27 - 46) 1995 Modelled IHME
36 (27 - 46) 1994 Modelled IHME
36 (27 - 45) 1993 Modelled IHME
36 (26 - 46) 1992 Modelled IHME
36 (26 - 46) 1991 Modelled IHME
36 (26 - 46) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
9.52 (%)
2019
(9.23 - 9.85(%))
IHME
HCV (RNA/cAg+)
3.24 (%)
2019
(2.58 - 4.05(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
363
2019
(207 - 601)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
374
2019
(225 - 604)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
3.31 (%)
2019, latest modelled
(2.94 - 3.75(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines